- Home
- PNI vs ME Comparison
PNI vs ME Comparison
Compare PNI & ME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNI
- ME
- Stock Information
- Founded
- PNI 2002
- ME 2006
- Country
- PNI United States
- ME United States
- Employees
- PNI N/A
- ME N/A
- Industry
- PNI Trusts Except Educational Religious and Charitable
- ME Precision Instruments
- Sector
- PNI Finance
- ME Health Care
- Exchange
- PNI Nasdaq
- ME Nasdaq
- Market Cap
- PNI 82.7M
- ME 68.4M
- IPO Year
- PNI N/A
- ME N/A
- Fundamental
- Price
- PNI $7.38
- ME $2.42
- Analyst Decision
- PNI
- ME Hold
- Analyst Count
- PNI 0
- ME 1
- Target Price
- PNI N/A
- ME $9.40
- AVG Volume (30 Days)
- PNI 26.4K
- ME 235.7K
- Earning Date
- PNI 01-01-0001
- ME 01-28-2025
- Dividend Yield
- PNI 4.76%
- ME N/A
- EPS Growth
- PNI N/A
- ME N/A
- EPS
- PNI N/A
- ME N/A
- Revenue
- PNI N/A
- ME $208,775,000.00
- Revenue This Year
- PNI N/A
- ME $22.00
- Revenue Next Year
- PNI N/A
- ME $17.31
- P/E Ratio
- PNI N/A
- ME N/A
- Revenue Growth
- PNI N/A
- ME N/A
- 52 Week Low
- PNI $6.03
- ME $2.42
- 52 Week High
- PNI $7.89
- ME $13.74
- Technical
- Relative Strength Index (RSI)
- PNI 62.02
- ME 32.49
- Support Level
- PNI $7.25
- ME $2.42
- Resistance Level
- PNI $7.32
- ME $2.96
- Average True Range (ATR)
- PNI 0.08
- ME 0.19
- MACD
- PNI 0.01
- ME 0.01
- Stochastic Oscillator
- PNI 95.00
- ME 0.00
About PNI Pimco New York Municipal Income Fund II of Beneficial Interest
PIMCO New York Municipal Income Fund II is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State and New York City income tax. The fund portfolio of investments consists of investments in different sectors such as education, transportation, healthcare, and others.
About ME 23andMe Holding Co.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.